Atlas Trials

Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants

Clinical trial NCT07218744 · COMPLETED

Trial details

NCT number
NCT07218744
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2025-11-13
Primary completion
2025-12-10
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.